Single-dose intra-articular bupivacaine significantly reduces pain after knee arthroscopy .
Single-dose intra-articular bupivacaine after knee arthroscopic surgery: a meta-analysis of randomized placebo-controlled studies
Knee Surg Sports Traumatol Arthrosc. 2014 Jul;22(7):1517-2823 studies comparing the use of single-dose intra-articular (IA) bupivacaine to placebo intervention for the reduction of pain following arthroscopic knee surgery were analyzed to determine if a single dose of intra-articular bupivacaine was a safe and effective pain management intervention. Results from the analysis demonstrated that a single IA dose of bupivacaine resulted in significantly less pain experienced by patients, significantly less supplementary analgesia required, and significantly longer time to first analgesic request when compared to placebo intervention. Short term side effects were comparable between the two interventions.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
